Pharmacokinetics of human leptin in mice and rhesus monkeys
- PMID: 11126209
- DOI: 10.1038/sj.ijo.0801447
Pharmacokinetics of human leptin in mice and rhesus monkeys
Abstract
Objective: The pharmacokinetic characteristics of human leptin were examined in rhesus monkeys and in C57BL/6J mice fed a normal chow or a high-fat diet.
Design: For the monkey study, in nine rhesus monkeys (body weight 12.4 +/- 2.4 kg; mean +/- s.d.), recombinant met-human leptin was injected intravenously or subcutaneously (1 mg/kg). For the mouse study, after 6 months of feeding C57BL/6J mice a high-fat diet (body weight 32.9 +/- 3.6 g; n = 8) or a control diet (24.5 +/- 1.2 g; n = 6), recombinant met-human leptin was administered intraperitoneally (10 microg/g). Blood samples were collected for leptin measurement at specific time points after leptin administration.
Measurements: Plasma leptin concentrations were determined by radioimmunoassay and pharmacokinetic analysis was performed.
Results: Disposition of human leptin in rhesus monkeys was biphasic following intravenous administration, with a terminal phase half-life of 96.4 +/- 16.5 min and clearance of 1.8 +/- 0.2 ml/min/kg. Subcutaneously administered leptin was absorbed slowly, perhaps by a zero-order process as leptin levels appeared to plateau and remained elevated throughout the 8 h sampling period. In C57BL/6J mice, the absorption and elimination of human leptin were both first-order following intraperitoneal administration. Pharmacokinetic parameters did not differ between normal-weight mice fed a chow diet and obese mice fed a high-fat diet. The elimination half-life was 47.0 +/- 26.4 min in mice fed a high-fat diet and 49.5 +/- 12.0 min in mice fed a control diet.
Conclusion: The kinetics of leptin in rhesus monkeys were biphasic and clearance was similar to values previously reported in humans. The estimated half-life was 96.4 min in rhesus monkeys and 49.5 min in normal weight mice. The was no difference in leptin kinetics between high-fat fed and control mice, suggesting that the increased baseline leptin levels in the obese mice are due to increased leptin production and secretion.
Similar articles
-
Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice.Int J Obes Relat Metab Disord. 2000 May;24(5):639-46. doi: 10.1038/sj.ijo.0801209. Int J Obes Relat Metab Disord. 2000. PMID: 10849588
-
Lipid profile in mice fed a high-fat diet after exogenous leptin administration.Pol J Pharmacol. 2003 Sep-Oct;55(5):763-9. Pol J Pharmacol. 2003. PMID: 14704473
-
Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey.Fertil Steril. 2002 Jun;77(6):1248-55. doi: 10.1016/s0015-0282(02)03113-8. Fertil Steril. 2002. PMID: 12057736
-
Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.Clin Pharmacokinet. 2008;47(11):753-64. doi: 10.2165/00003088-200847110-00006. Clin Pharmacokinet. 2008. PMID: 18840030 Free PMC article.
-
The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice.Regul Pept. 2008 Oct 9;150(1-3):62-5. doi: 10.1016/j.regpep.2008.03.008. Epub 2008 Mar 26. Regul Pept. 2008. PMID: 18455249
Cited by
-
Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1.Mol Cell Biol. 2013 Mar;33(5):918-26. doi: 10.1128/MCB.01227-12. Epub 2012 Dec 21. Mol Cell Biol. 2013. PMID: 23263987 Free PMC article.
-
Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.Obes Surg. 2011 Oct;21(10):1597-604. doi: 10.1007/s11695-011-0414-1. Obes Surg. 2011. PMID: 21494811
-
Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.ILAR J. 2017 Dec 1;58(2):251-268. doi: 10.1093/ilar/ilx031. ILAR J. 2017. PMID: 29216341 Free PMC article. Review.
-
Metreleptin: first global approval.Drugs. 2013 Jun;73(9):989-97. doi: 10.1007/s40265-013-0074-7. Drugs. 2013. PMID: 23740412 Review.
-
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2007 Jul 14;13(26):3540-53. doi: 10.3748/wjg.v13.i26.3540. World J Gastroenterol. 2007. PMID: 17659704 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous